[HTML][HTML] Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior

V András, J Tomek, N Nagy, L Virág… - Physiological …, 2021 - journals.physiology.org
Cardiac arrhythmias are among the leading causes of mortality. They often arise from
alterations in the electrophysiological properties of cardiac cells and their underlying ionic …

Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine

BJ Maron, SR Ommen, C Semsarian, P Spirito… - Journal of the American …, 2014 - jacc.org
Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with diverse
phenotypic and genetic expression, clinical presentation, and natural history. HCM has been …

Human In Silico Drug Trials Demonstrate Higher Accuracy than Animal Models in Predicting Clinical Pro-Arrhythmic Cardiotoxicity

E Passini, OJ Britton, HR Lu, J Rohrbacher… - Frontiers in …, 2017 - frontiersin.org
Early prediction of cardiotoxicity is critical for drug development. Current animal models
raise ethical and translational questions, and have limited accuracy in clinical risk prediction …

Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block

J Tomek, A Bueno-Orovio, E Passini, X Zhou… - Elife, 2019 - elifesciences.org
Human-based modelling and simulations are becoming ubiquitous in biomedical science
due to their ability to augment experimental and clinical investigations. Cardiac …

CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for …

D Mosqueira, I Mannhardt, JR Bhagwan… - European heart …, 2018 - academic.oup.com
Aims Sarcomeric gene mutations frequently underlie hypertrophic cardiomyopathy (HCM), a
prevalent and complex condition leading to left ventricle thickening and heart dysfunction …

[HTML][HTML] Ferroptosis and its role in cardiomyopathy

D Li, W Pi, Z Sun, X Liu, J Jiang - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Heart disease is the leading cause of death worldwide. Cardiomyopathy is a disease
characterized by the heart muscle damage, resulting heart in a structurally and functionally …

Hypertrophic cardiomyopathy: the future of treatment

CV Tuohy, S Kaul, HK Song, B Nazer… - European journal of …, 2020 - Wiley Online Library
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic disorder most often caused
by sarcomeric mutations resulting in left ventricular hypertrophy, fibrosis, hypercontractility …

[HTML][HTML] Electro-mechanical whole-heart digital twins: a fully coupled multi-physics approach

T Gerach, S Schuler, J Fröhlich, L Lindner… - Mathematics, 2021 - mdpi.com
Mathematical models of the human heart are evolving to become a cornerstone of precision
medicine and support clinical decision making by providing a powerful tool to understand …

Genetics of hypertrophic cardiomyopathy: A review of current state

M Sabater‐Molina, I Pérez‐Sánchez… - Clinical …, 2018 - Wiley Online Library
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease.
HCM is a highly complex and heterogeneous disease regarding not only the number of …

Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on …

J van der Velden, FW Asselbergs… - Cardiovascular …, 2022 - academic.oup.com
Cardiovascular diseases represent a major cause of morbidity and mortality, necessitating
research to improve diagnostics, and to discover and test novel preventive and curative …